Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$8,184,911
+$1,917,599 QoQ
Shares Held
6,824
+0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
3.19%
of 13F equity value
Holder Rank
#1,368
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TCI Wealth Advisors, Inc. holds $24,505,177 across 8 Drug Manufacturers - General names. LLY ranks #2 (33.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
38,577 | $9,797,400 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
6,824 | $8,184,911 | |
| 3 | ABBV |
AbbVie Inc.
|
15,431 | $3,883,056 | |
| 4 | MRK |
Merck & Co., Inc.
|
9,242 | $1,187,597 | |
| 5 | AMGN |
Amgen Inc
|
1,691 | $612,344 | |
| 6 | PFE |
Pfizer Inc
|
15,257 | $367,388 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,558 | $262,631 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,661 | $209,850 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,184,911 | 6,824 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $6,267,312 | 6,814 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $8,652,249 | 8,051 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $6,170,381 | 8,087 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $6,272,877 | 8,047 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $6,684,089 | 8,093 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $6,351,244 | 8,227 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $7,261,164 | 8,196 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $7,385,184 | 8,157 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $6,336,484 | 8,145 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $4,722,234 | 8,101 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $4,009,138 | 7,464 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $3,495,776 | 7,454 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $2,543,025 | 7,405 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $2,642,462 | 7,223 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,357,221 | 7,290 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $2,384,711 | 7,355 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $1,935,288 | 6,758 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $1,971,934 | 7,139 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $1,751,359 | 7,580 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $1,847,406 | 8,049 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,506,142 | 8,062 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $1,362,032 | 8,067 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $2,145,549 | 14,495 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $2,429,043 | 14,795 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $2,050,697 | 14,783 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||